Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma.
Saved in:
| Title: | Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma. |
|---|---|
| Authors: | Li X; Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, Guangdong, People's Republic of China., Chen D; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China., Guo Y; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China., Huang G; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China., Cai Z; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China., Xue T; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Chen Z; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China., Han H; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. hanhui@sysucc.org.cn.; Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. hanhui@sysucc.org.cn.; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 10060, Guangdong, People's Republic of China. hanhui@sysucc.org.cn., Li Z; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China. lizaishang2017@163.com.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China. lizaishang2017@163.com.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China. lizaishang2017@163.com. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 17; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41843154 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Association of CCL21<superscript>+</superscript> CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, Guangdong, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Chen+D%22">Chen D</searchLink>; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Guo+Y%22">Guo Y</searchLink>; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Huang+G%22">Huang G</searchLink>; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Cai+Z%22">Cai Z</searchLink>; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Xue+T%22">Xue T</searchLink>; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Han+H%22">Han H</searchLink>; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. hanhui@sysucc.org.cn.; Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. hanhui@sysucc.org.cn.; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 10060, Guangdong, People's Republic of China. hanhui@sysucc.org.cn.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China. lizaishang2017@163.com.; Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China. lizaishang2017@163.com.; Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China. lizaishang2017@163.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2026 Mar 17; Vol. 75 (4). <i>Date of Electronic Publication: </i>2026 Mar 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41843154 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-026-04348-5 Languages: – Code: eng Text: English Titles: – TitleFull: Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Chen D – PersonEntity: Name: NameFull: Guo Y – PersonEntity: Name: NameFull: Huang G – PersonEntity: Name: NameFull: Cai Z – PersonEntity: Name: NameFull: Xue T – PersonEntity: Name: NameFull: Chen Z – PersonEntity: Name: NameFull: Han H – PersonEntity: Name: NameFull: Li Z IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 03 Text: 2026 Mar 17 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 75 – Type: issue Value: 4 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |